- Global Pharma News & Resources

Press Releases - 2023-03-28

Date Title Company
28-Mar-2023 CureVac Announces Voting Results of Extraordinary General Meeting CureVac
28-Mar-2023 Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards B3C newswire
28-Mar-2023 Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients Evaxion
28-Mar-2023 Women Leaders Coming Together for Fourth Annual Medtech Conference MedExecWomen
28-Mar-2023 SRG appoints Andrew Turner as Global Managing Director SRG
28-Mar-2023 HMNC Brain Health and Develco Pharma Announce Last Patient Being Randomized in Oral Prolonged-Release Ketamine (KET01) Trial for Treatment-Resistant Depression HMNC Brain Health
28-Mar-2023 MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology MIMETAS
28-Mar-2023 Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in broad population of patients with early breast cancer Novartis
28-Mar-2023 Tiziana Life Sciences to Proceed with Phase 2 Clinical Trial in Patients with Non-Active Secondary Progressive Multiple Sclerosis (SPMS) Tiziana Life Sciences
28-Mar-2023 MMIP chair responds to Life Sciences Innovative Manufacturing Fund grants announcement ABPI
28-Mar-2023 AlzeCure presents new data on its preventive treatment Alzstatin at the Alzheimer's conference AD/PD 2023 AlzeCure
28-Mar-2023 MaxBio+ creates an insulin spray – heralding an end to insulin needles MaxBio+
28-Mar-2023 softgate joins BlackBerry Value-Added Integrator Program To Accelerate Safety-Critical Medical Software Innovation softgate
28-Mar-2023 1nHealth Launches Site Advisory Board to Prioritize Site Voice Newswire
28-Mar-2023 MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology B3C newswire
28-Mar-2023 InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Health InfanDx
28-Mar-2023 Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001 Thermosome
28-Mar-2023 Yunu Opens the Yunuverse, Increasing Trial Access for Patients and Solving Staffing Challenges for Cancer Centers, Pharma, and CRO Customers Newswire
28-Mar-2023 Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry Newron Pharmaceuticals S.p.A.